Bleomycin-induced lung injury in mice investigated by MRI: Model assessment for target analysis

Magnetic Resonance in Medicine

Volumn 67, Issue 2, 2012, Pages 499-509

  Babin, Anna L ^a,b   Cannet, Catherine ^a   Gérard, Christelle ^a   Saint Mezard, Pierre ^a   Page, Clive P ^b   Sparrer, Helmut ^a   Matsuguchi, Tetsuya ^c   Beckmann, Nicolau ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

bleomycin; cancer Osaka thyroid kinase; fibrosis; imaging; lung; magnetic resonance imaging; mouse; pulmonary fibrosis

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; ENZYMES; HISTOLOGY; IMAGING TECHNIQUES; MAMMALS; PEPTIDES;

BLEOMYCINS; CANCER OSAKA THYROID KINASE; FIBROSIS; LUNG; MOUSE; PULMONARY FIBROSIS;

MAGNETIC RESONANCE IMAGING;

BLEOMYCIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HISTOLOGY; LOW DRUG DOSE; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 84856219461     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.23009     Document Type: Article

References (47)

1. Gross TJ, Hunninghake GW,. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345: 517-525. (Pubitemid 32758505)
2. Ask K, Labiris R, Farkas L, Moeller A, Froese A, Farncombe T, McClelland GB, Inman M, Gauldie J, Kolb MR,. Comparison between conventional and "clinical" assessment of experimental lung fibrosis. J Transl Med 2008; 6: 1.
3. Lazo JS, Sebti SM, Schellens JH,. Bleomycin. Cancer Chemother Biol Response Modif 1996; 16: 39-47.
4. O'Sullivan JM, Huddart RA, Norman AR, Nicholls J, Dearnaley DP, Horwich A,. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol 2003; 14: 91-96. (Pubitemid 36150265)
5. Azambuja E, Fleck JF, Batista RG, Menna Barreto SS,. Bleomycin lung toxicity: who are the patients with increased risk? Pulm Pharmacol Ther 2005; 18: 363-366. (Pubitemid 40804534)
6. Moore BB, Hogaboam CM,. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008; 294: 152-160.
7. Chua F, Gauldie J, Laurent GJ,. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 2005; 33: 9-13. (Pubitemid 40961008)
8. Miyoshi J, Higashi T, Mukai H, Ohuchi T, Kakunaga T,. Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Mol Cell Biol 1991; 11: 4088-4096. (Pubitemid 21895798)
9. Aoki M, Hamada F, Sugimoto T, Sumida S, Akiyama T, Toyoshima K,. The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J Biol Chem 1993; 268: 22723-22732. (Pubitemid 23318331)
10. Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, Patriotis C, Jenkins NA, Copeland NG, Kollias, G, Tsichlis PN,. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000; 103: 1071-1083. (Pubitemid 32040907)
11. Sullivan DE, Ferris M, Pociask D, Brody AR,. Tumor necrosis factor-alpha induces transforming growth factor-beta 1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol 2005; 32: 342-349. (Pubitemid 40478310)
12. Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, Schnyder B, Akira S, Quesniaux VF, Lagente V, Ryffel B, Couillin I,. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 2007; 117: 3786-3799. (Pubitemid 350224089)
13. Thomay AA, Daley JM, Sabo E, Worth PJ, Shelton LJ, Harty MW, Reichner JS, Albina JE,. Disruption of interleukin-1 signaling improves the quality of wound healing. Am J Pathol 2009; 174: 2129-2136.
14. Forino M, Torregrossa R, Ceol M, Murer L, Della Vella M, Del Prete D, D'Angelo A, Anglani F,. TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol 2006; 87: 197-208. (Pubitemid 43781685)
15. Thiery JP, Acloque H, Huang RY, Nieto MA,. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
16. Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, Shimokata K, Hasegawa Y,. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010; 43: 161-172.
17. Sugimoto K, Ohata M, Miyoshi J, Ishizaki H, Tsuboi N, Masuda A, Yoshikai Y, Takamoto M, Sugane K, Matsuo S, Shimada Y, Matsuguchi T,. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. J Clin Invest 2004; 114: 857-866. (Pubitemid 39578745)
18. Horikawa K, Radice G, Takeichi M, Chisaka O,. Adhesive subdivisions intrinsic to the epithelial somites. Dev Biol 1999; 215: 182-189.
19. Blé FX, Cannet C, Zurbruegg S, Karmouty-Quintana H, Bergmann R, Frossard N, Trifilieff A, Beckmann N,. Allergen-induced lung inflammation in actively sensitized mice assessed with MR imaging. Radiology 2008; 248: 834-843.
20. Sood BG, Dawe EJ, Maddipati KR, Malian M, Chen X, Galli R, Rabah R,. Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs. Pulm Pharmacol Ther 2008; 21: 565-572. (Pubitemid 351625939)
21. Hardie WD, Glasser SW, Hagood JS,. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 2009; 175: 3-16.
22. Wurfel MM,. Microarray-based analysis of ventilator-induced lung injury. Proc Am Thorac Soc 2007; 4: 77-84. (Pubitemid 46067566)
23. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R,. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 2002; 83: 111-119. (Pubitemid 35286131)
24. Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE,. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010; 299: L442-L452.
25. Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelly EF, Holburn GE, Lewis KG, Collins RD, Hull WM, Glasser SW, Whitsett JA, Blackwell TS,. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol 2005; 167: 1267-1277. (Pubitemid 41541413)
26. Lekgabe ED, Royce SG, Hewitson TD, Tang ML, Zhao C, Moore XL, Tregear GW, Bathgate RA, Du XJ, Samuel CS,. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs. Endocrinology 2006; 147: 5575-5583. (Pubitemid 44833474)
27. Schrier DJ, Kunkel RG, Phan SH,. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1983; 127: 63-66. (Pubitemid 13168313)
28. Rossi GA, Szapiel S, Ferrans VJ, Crystal RG,. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune related genes. Am Rev Respir Dis 1987; 135: 448-455. (Pubitemid 17012112)
29. Sebti SM, Mignano JE, Jani JP, Srimatkandada S, Lazo JS,. Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry 1989; 28: 6544-6548. (Pubitemid 19208303)
30. Haston CK, Tomko TG, Godin N, Kerckhoff L, Hallett MT,. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. J Med Genet 2005; 42: 464-473. (Pubitemid 40847233)
31. Wheelock MJ, Johnson KR,. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 2003; 19: 207-235. (Pubitemid 37487348)
32. Locascio A, Nieto MA,. Cell movements during vertebrate development: integrated tissue behaviour versus individual cell migration. Curr Opin Genet Dev 2001; 11: 464-469. (Pubitemid 32614207)
33. van Roy F, Berx G,. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756-3788.
34. López-Novoa JM, Nieto MA,. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 2009; 1: 303-314.
35. Cutillo AG, Chan PH, Ailion DC, Watanabe S, Rao NV, Hansen CB, Albertine KH, Laicher G, Durney CH,. Characterization of bleomycin lung injury by nuclear magnetic resonance: correlation between NMR relaxation times and lung water and collagen content. Magn Reson Med 2002; 47: 246-256. (Pubitemid 34116792)
36. Karmouty-Quintana H, Cannet C, Zurbruegg S, Blé FX, Fozard JR, Page CP, Beckmann N,. Bleomycin-induced lung injury assessed non-invasively and in spontaneously breathing rats by proton MRI. J Magn Reson Imaging 2007; 26: 941-949. (Pubitemid 47554237)
37. Jacob RE, Amidan BG, Soelberg J, Minard KR,. In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis. J Magn Reson Imaging 2010; 31: 1091-1099.
38. Babin AL, Cannet C, Gérard C, Wyss D, Page CP, Beckmann N,. Non-invasive assessment of bleomycin-induced lung injury and the effects of short term glucocorticosteroid treatment in rats using MRI. J Magn Reson Imaging 2011; 33: 603-614.
39. Helm PA, Caravan P, French BA, Jacques V, Shen L, Xu Y, Beyers RJ, Roy RJ, Kramer CM, Epstein FH,. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology 2008; 247: 788-796.
40. Thomeer M, Demedts M, Behr J, Buhl R, Costabel U, Flower CD, Verschakelen J, Laurent F, Nicholson AG, Verbeken EK, Capron F, Sardina M, Corvasce G, Lankhorst I,; Idiopathic Pulmonary Fibrosis International Group Exploring N-Acetylcysteine I Annual (IFIGENIA) study group. Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J 2008; 31: 585-591.
41. Schmidt SL, Sundaram B, Flaherty KR,. Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis? Respirology 2009; 14: 934-939.
42. Lee HJ, Goo JM, Kim NR, Kim MA, Chung DH, Son KR, Kim HC, Lee CH, Park CM, Chun EJ, Im JG,. Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores-initial results. Invest Radiol 2008; 43: 453-460. (Pubitemid 351769905)
43. Shofer S, Badea C, Qi Y, Potts E, Foster WM, Johnson GA,. A micro-CT analysis of murine lung recruitment in bleomycin-induced lung injury. J Appl Physiol 2008; 105: 669-677.
44. van Echteld CJA, Beckmann N,. A view on imaging in drug research and development for respiratory diseases. J Pharmacol Exper Ther 2011; 337: 335-349.
45. Boone JM, Velazquez O, Cherry SR,. Small-animal X-ray dose from micro-CT. Mol Imaging 2004; 3: 149-158.
46. Puderbach M, Eichinger M, Haeselbarth J, Ley S, Kopp-Schneider A, Tuengerthal S, Schmaehl A, Fink C, Plathow C, Wiebel M, Demirakca S, Müller FM, Kauczor HU,. Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest X-ray. Invest Radiol 2007; 42: 715-725. (Pubitemid 351325904)
47. Hekimoǧlu K, Sancak T, Tor M, Beşir H, Kalaycioǧlu B, Gündoǧdu S,. Fast MRI evaluation of pulmonary progressive massive fibrosis with VIBE and HASTE sequences: comparison with CT. Diagn Interv Radiol 2010; 16: 30-37.